" class="no-js "lang="en-US"> IVX Health Announces Opening of New Infusion Centers in Connecticut - Medtech Alert
Friday, April 12, 2024

IVX Health Announces Opening of New Infusion Centers in Connecticut

IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two infusion centers in the greater Hartford and New Haven areas, with plans to open more centers in the state of Connecticut over the coming year. IVX Health currently operates over 60 centers within 22 metropolitan areas across the United States.

Exclusively serving immunocompromised patients, IVX centers are intentionally designed with patient-focused amenities such as guaranteed private suites, large leather recliners, flat screen TVs with streaming options, and more. IVX Health centers are conveniently located in the communities where patients live and work and offer flexible appointment scheduling, ensuring patients can weave care into their daily lives and routines.

“We are thrilled to introduce IVX Health to the healthcare community in Connecticut,” said Doug Ghertner, CEO of IVX Health. “We partner with referring specialists like gastroenterologists, rheumatologists, neurologists, and others to simplify getting their patients on therapy while quickly facilitating the prior authorization and benefits eligibility processes so they can remain focused on what’s most important – providing exceptional patient care. IVX Health is trusted by providers and their teams because of our unwavering dedication to clinical excellence.”

The Connecticut infusion centers contribute to IVX Health’s impressive growth and national footprint. This year alone, IVX will open new centers in CharlotteRaleighPalm BeachFt. LauderdaleSarasotaBradentonFort MyersOrlandoJacksonville, and San Francisco – resulting in over 70 locations nationwide by the end of 2022.

“IVX’s presence in Connecticut will offer patients and their referring specialists a convenient, private site of care that truly focuses on the patient’s safety, comfort, and well-being,” noted Jason Bruns, director of operational deployment with IVX Health. “With our refined clinical model and scale of expertise providing infusion and injection care, IVX consistently delivers a world-class care experience for our patients. We truly believe there is no better place to receive this type of ongoing care.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more